Table I.
Patient Baseline Characteristics According to Microalbumin Group
| Group 1 | Group 2 | Group 3 | Group 4 | P Value | |
|---|---|---|---|---|---|
| N (M) | 1659 (767) | 1675 (849) | 1656 (869) | 1660 (896) | NS |
| Age, y | 53.5±13.0 | 53.1±12.2 | 53.3±12.8 | 54.9±12.8 | <.001 |
| WtoHeight | 5.30±6.41 | 5.36±6.41 | 5.39±6.24 | 5.53±6.41 | <.001 |
| BMI, kg/m2 | 26.8±4.2 | 27.4±3.9 | 27.4±4.0 | 28.0±4.2 | <.001 |
| Waist, %a | 27.7 | 27.7 | 29.6 | 35.0 | <.001 |
| MLK, mg/L | 5.8±2.03 | 9.61±7.12 | 12.84±1.28 | 17.67±1.38 | <.001 |
| Male sex, % | 46.2 | 50.7 | 52.5 | 54 | <.001 |
| MetS‐WHO, % | 16 | 17.8 | 22.2 | 26.7 | <.001 |
| MetS‐NCEP, % | 22.1 | 30.0 | 31.6 | 39 | <.001 |
| MetS‐GISSI, % | 22.3 | 26.3 | 32.1 | 37.7 | <.001 |
| ATP‐MetS, % | 16 | 23.7 | 24.7 | 29.9 | <.001 |
| MetS‐IDF, % | 31.3 | 39 | 41.8 | 46.1 | <.001 |
| IGT, % | 8.6 | 11.3 | 13.8 | 14.2 | <.001 |
| IFG, % | 16 | 16.3 | 17.8 | 22.7 | <.001 |
Abbreviations: ATP‐MetS, metabolic syndrome definition according to Adult Treatment Panel III; BMI, body mass index; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; M, male; MLK, microalbumin; MetS‐IDF, metabolic syndrome definition according to the International Diabetes Federation; MetS‐GISSI, metabolic syndrome Gruppo Italiano per lo Studio della Streptochinasi nell’Infarcto Miocardico score system; MetS‐NCEP, metabolic syndrome definition according to the National Cholesterol Education Program; MetS‐WHO, metabolic syndrome definition according to the World Health Organization; NS, not significant; WtoHeight, waist to height. aWaist, % is >102 cm for men and >88 cm for women.